Please choose an event type to view the corresponding MedsFacts report:

HEPATIC FUNCTION ABNORMAL ( 13 FDA reports)
PYREXIA ( 13 FDA reports)
CYTOMEGALOVIRUS INFECTION ( 8 FDA reports)
RENAL IMPAIRMENT ( 8 FDA reports)
ALANINE AMINOTRANSFERASE INCREASED ( 7 FDA reports)
C-REACTIVE PROTEIN INCREASED ( 7 FDA reports)
DISSEMINATED INTRAVASCULAR COAGULATION ( 7 FDA reports)
THERAPEUTIC RESPONSE DECREASED ( 7 FDA reports)
ASPARTATE AMINOTRANSFERASE INCREASED ( 6 FDA reports)
BLOOD PRESSURE SYSTOLIC DECREASED ( 6 FDA reports)
BONE MARROW FAILURE ( 6 FDA reports)
ELECTROCARDIOGRAM QT PROLONGED ( 6 FDA reports)
EOSINOPHIL COUNT INCREASED ( 6 FDA reports)
PLEURAL EFFUSION ( 6 FDA reports)
RESPIRATORY ARREST ( 6 FDA reports)
URINE OUTPUT DECREASED ( 6 FDA reports)
ACUTE GRAFT VERSUS HOST DISEASE ( 5 FDA reports)
OEDEMA ( 5 FDA reports)
PNEUMONIA ( 5 FDA reports)
BLOOD ALKALINE PHOSPHATASE INCREASED ( 4 FDA reports)
BLOOD CALCIUM DECREASED ( 4 FDA reports)
BLOOD UREA INCREASED ( 4 FDA reports)
CEREBRAL HAEMORRHAGE ( 4 FDA reports)
CONDITION AGGRAVATED ( 4 FDA reports)
FEBRILE NEUTROPENIA ( 4 FDA reports)
HAEMOGLOBIN DECREASED ( 4 FDA reports)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION ( 4 FDA reports)
NEUTROPHIL COUNT DECREASED ( 4 FDA reports)
PLATELET COUNT DECREASED ( 4 FDA reports)
RASH ( 4 FDA reports)
SEPSIS ( 4 FDA reports)
STAPHYLOCOCCAL INFECTION ( 4 FDA reports)
ABDOMINAL PAIN UPPER ( 3 FDA reports)
ACUTE PROMYELOCYTIC LEUKAEMIA ( 3 FDA reports)
ADENOVIRAL HAEMORRHAGIC CYSTITIS ( 3 FDA reports)
ANAEMIA ( 3 FDA reports)
APLASTIC ANAEMIA ( 3 FDA reports)
ARRHYTHMIA ( 3 FDA reports)
BLOOD BILIRUBIN INCREASED ( 3 FDA reports)
BLOOD CREATINE PHOSPHOKINASE INCREASED ( 3 FDA reports)
BLOOD LACTATE DEHYDROGENASE INCREASED ( 3 FDA reports)
CLOSTRIDIUM DIFFICILE COLITIS ( 3 FDA reports)
ENTEROCOCCAL SEPSIS ( 3 FDA reports)
GRAFT VERSUS HOST DISEASE ( 3 FDA reports)
HYPOKALAEMIA ( 3 FDA reports)
MALAISE ( 3 FDA reports)
RESPIRATORY DISORDER ( 3 FDA reports)
RESUSCITATION ( 3 FDA reports)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED ( 2 FDA reports)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN ( 2 FDA reports)
BLOOD ALBUMIN DECREASED ( 2 FDA reports)
BLOOD PRESSURE DECREASED ( 2 FDA reports)
BLOOD SODIUM DECREASED ( 2 FDA reports)
BLOOD URIC ACID INCREASED ( 2 FDA reports)
BRONCHOPULMONARY ASPERGILLOSIS ( 2 FDA reports)
CARDIAC FAILURE CONGESTIVE ( 2 FDA reports)
CENTRAL NERVOUS SYSTEM INFECTION ( 2 FDA reports)
CHRONIC GRAFT VERSUS HOST DISEASE ( 2 FDA reports)
CLOSTRIDIUM COLITIS ( 2 FDA reports)
CYTOMEGALOVIRUS VIRAEMIA ( 2 FDA reports)
DEATH ( 2 FDA reports)
DIARRHOEA ( 2 FDA reports)
DISEASE PROGRESSION ( 2 FDA reports)
ESCHERICHIA SEPSIS ( 2 FDA reports)
FIBRIN DEGRADATION PRODUCTS INCREASED ( 2 FDA reports)
FREQUENT BOWEL MOVEMENTS ( 2 FDA reports)
FUNGAL INFECTION ( 2 FDA reports)
GAMMA-GLUTAMYLTRANSFERASE INCREASED ( 2 FDA reports)
HAEMOLYTIC URAEMIC SYNDROME ( 2 FDA reports)
HYPERGLYCAEMIA ( 2 FDA reports)
INFECTION ( 2 FDA reports)
INTESTINAL OBSTRUCTION ( 2 FDA reports)
JAUNDICE ( 2 FDA reports)
LARGE INTESTINE PERFORATION ( 2 FDA reports)
LEUKOPENIA ( 2 FDA reports)
LUNG DISORDER ( 2 FDA reports)
MALIGNANT NEOPLASM PROGRESSION ( 2 FDA reports)
MYOCLONIC EPILEPSY ( 2 FDA reports)
NEUROPATHY PERIPHERAL ( 2 FDA reports)
NO THERAPEUTIC RESPONSE ( 2 FDA reports)
OCCULT BLOOD ( 2 FDA reports)
PERITONITIS ( 2 FDA reports)
PNEUMOTHORAX ( 2 FDA reports)
PROTEIN TOTAL DECREASED ( 2 FDA reports)
PROTHROMBIN LEVEL DECREASED ( 2 FDA reports)
PULMONARY ALVEOLAR HAEMORRHAGE ( 2 FDA reports)
RECTAL STENOSIS ( 2 FDA reports)
RECTAL ULCER ( 2 FDA reports)
RENAL FAILURE ( 2 FDA reports)
RENAL FAILURE ACUTE ( 2 FDA reports)
SCAR ( 2 FDA reports)
SUBILEUS ( 2 FDA reports)
THROMBOCYTOPENIA ( 2 FDA reports)
THYROID DISORDER ( 2 FDA reports)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE ( 1 FDA reports)
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER ( 1 FDA reports)
ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME ( 1 FDA reports)
ANAPHYLACTIC SHOCK ( 1 FDA reports)
ATRIAL FIBRILLATION ( 1 FDA reports)
BLOOD CREATININE INCREASED ( 1 FDA reports)
BLOOD POTASSIUM DECREASED ( 1 FDA reports)
BLOOD POTASSIUM INCREASED ( 1 FDA reports)
BLOOD PRESSURE INCREASED ( 1 FDA reports)
BRONCHIAL OBSTRUCTION ( 1 FDA reports)
BRONCHOMALACIA ( 1 FDA reports)
CEREBRAL INFARCTION ( 1 FDA reports)
CEREBROVASCULAR DISORDER ( 1 FDA reports)
CLOSTRIDIUM TEST POSITIVE ( 1 FDA reports)
CRYING ( 1 FDA reports)
CYANOSIS ( 1 FDA reports)
CYTOMEGALOVIRUS TEST POSITIVE ( 1 FDA reports)
DECREASED APPETITE ( 1 FDA reports)
DEPRESSED LEVEL OF CONSCIOUSNESS ( 1 FDA reports)
DISEASE RECURRENCE ( 1 FDA reports)
DRUG INEFFECTIVE ( 1 FDA reports)
DRUG LEVEL INCREASED ( 1 FDA reports)
ENCEPHALITIS ( 1 FDA reports)
ENTEROCOCCAL INFECTION ( 1 FDA reports)
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER ( 1 FDA reports)
FACE OEDEMA ( 1 FDA reports)
GASTRIC MUCOSAL LESION ( 1 FDA reports)
GASTROINTESTINAL DISORDER ( 1 FDA reports)
GASTROINTESTINAL OEDEMA ( 1 FDA reports)
GRANULOMA ( 1 FDA reports)
HAEMODIALYSIS ( 1 FDA reports)
HEPATIC ENZYME INCREASED ( 1 FDA reports)
HYPOAESTHESIA ( 1 FDA reports)
IMMOBILE ( 1 FDA reports)
INFLAMMATION ( 1 FDA reports)
INTESTINAL DILATATION ( 1 FDA reports)
INTESTINAL ISCHAEMIA ( 1 FDA reports)
INTESTINAL ULCER ( 1 FDA reports)
ISCHAEMIC ULCER ( 1 FDA reports)
LEUKOCYTOSIS ( 1 FDA reports)
LOSS OF CONSCIOUSNESS ( 1 FDA reports)
LUNG NEOPLASM MALIGNANT ( 1 FDA reports)
LYMPHOCYTE COUNT DECREASED ( 1 FDA reports)
MELAENA ( 1 FDA reports)
METASTASES TO BONE ( 1 FDA reports)
MOVEMENT DISORDER ( 1 FDA reports)
MUSCULAR WEAKNESS ( 1 FDA reports)
MYOSITIS ( 1 FDA reports)
NEUROBLASTOMA ( 1 FDA reports)
OEDEMA PERIPHERAL ( 1 FDA reports)
PALPITATIONS ( 1 FDA reports)
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER ( 1 FDA reports)
RECTAL CANCER ( 1 FDA reports)
SHOCK ( 1 FDA reports)
STAPHYLOCOCCAL SEPSIS ( 1 FDA reports)
TRANSAMINASES INCREASED ( 1 FDA reports)
VENTRICULAR EXTRASYSTOLES ( 1 FDA reports)
VOMITING ( 1 FDA reports)
WHITE BLOOD CELL COUNT DECREASED ( 1 FDA reports)

© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use